Yang Rui, Ma Mingjun, Yu Sihui, Li Xi, Zhang Jiawen, Wu Sufang
Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Reproductive Medicine Center, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Front Oncol. 2021 Oct 4;11:742017. doi: 10.3389/fonc.2021.742017. eCollection 2021.
Peptidase domain containing associated with muscle regeneration 1 (PAMR1) is frequently lost in breast cancer samples and is considered as a tumor suppressor. The roles and mechanisms of PAMR1 in other types of cancers are still unclear. In our present study, we identified PAMR1 as an invasion-related regulator in cervical cancer. Public database and immunohistochemical (IHC) analysis showed that the expression level of PAMR1 in cervical cancer tissues was lower than that in normal cervix tissues and was negatively related to clinicopathologic features. The high expression of PAMR1 also predicted a better prognosis of cervical cancer patients. CCK8, Transwell, and wound-healing assays demonstrated that knockdown of PAMR1 facilitated the proliferation, migration, and invasion of cervical cancer cells. Additionally, gene set enrichment analysis (GSEA) showed a variety of cancer-related pathways potentially activated or suppressed by PAMR1. Moreover, we verified that PAMR1 inhibited MYC target and mTORC1 signaling pathways. In conclusion, our study revealed the suppressor role of PAMR1 in cervical cancer, providing a new insight into the molecular mechanism of cervical cancer progression.
含肽酶结构域且与肌肉再生相关的蛋白1(PAMR1)在乳腺癌样本中经常缺失,被认为是一种肿瘤抑制因子。PAMR1在其他类型癌症中的作用和机制仍不清楚。在我们目前的研究中,我们确定PAMR1是宫颈癌中的一种侵袭相关调节因子。公共数据库和免疫组织化学(IHC)分析表明,PAMR1在宫颈癌组织中的表达水平低于正常宫颈组织,且与临床病理特征呈负相关。PAMR1的高表达也预示着宫颈癌患者的预后较好。CCK8、Transwell和伤口愈合试验表明,敲低PAMR1可促进宫颈癌细胞的增殖、迁移和侵袭。此外,基因集富集分析(GSEA)显示了多种可能被PAMR1激活或抑制的癌症相关通路。此外,我们证实PAMR1抑制MYC靶标和mTORC1信号通路。总之,我们的研究揭示了PAMR1在宫颈癌中的抑制作用,为宫颈癌进展的分子机制提供了新的见解。